Schedule 13D ownership disclosure
ASCENDIS PHARMA A/S
Security class unavailable · CUSIP: 04351P101
Event date: 2016-06-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.9100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-16-001278
- Form type
- SC 13D
- Filer
- Ascendis Pharma A/S
- CIK
- CIK 1612042
- Filed
- Jun 17, 2016
- Reporting period
- Jun 15, 2016
- Description
- Schedule 13D beneficial ownership